Literature DB >> 22864966

Sulpiride and refractory panic disorder.

Emerson A Nunes, Rafael C Freire, Moema Dos Reis, Adriana Cardoso de Oliveira E Silva, Sérgio Machado, José A S Crippa, Serdar M Dursun, Glen B Baker, Jaime E C Hallak, Antonio E Nardi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22864966     DOI： 10.1007/s00213-012-2818-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  12 in total

1.  l-Sulpiride, at a low, non-neuroleptic dose, prevents conditioned fear stress-induced freezing behavior in rats.

Authors:  E Cavazzuti; A Bertolini; A V Vergoni; R Arletti; R Poggioli; A Forgione; A Benelli
Journal:  Psychopharmacology (Berl)       Date:  1999-03       Impact factor: 4.530

Review 2.  Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.

Authors:  S Miyamoto; G E Duncan; C E Marx; J A Lieberman
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

Review 3.  Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis.

Authors:  Miguel Pérez de la Mora; Andrea Gallegos-Cari; Yexel Arizmendi-García; Daniel Marcellino; Kjell Fuxe
Journal:  Prog Neurobiol       Date:  2009-10-21       Impact factor: 11.685

4.  Antidepressant action of sulpiride. Results of a placebo-controlled double-blind trial.

Authors:  E Rüther; D Degner; U Munzel; E Brunner; G Lenhard; J Biehl; U Vögtle-Junkert
Journal:  Pharmacopsychiatry       Date:  1999-07       Impact factor: 5.788

5.  Management of treatment-resistant panic disorder.

Authors:  Richard L Holt; R Bruce Lydiard
Journal:  Psychiatry (Edgmont)       Date:  2007-10

6.  National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders.

Authors:  Jonathan S Comer; Ramin Mojtabai; Mark Olfson
Journal:  Am J Psychiatry       Date:  2011-07-28       Impact factor: 18.112

Review 7.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

8.  Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

Authors:  Robert M Berman; Maurizio Fava; Michael E Thase; Madhukar H Trivedi; René Swanink; Robert D McQuade; William H Carson; David Adson; Leslie Taylor; James Hazel; Ronald N Marcus
Journal:  CNS Spectr       Date:  2009-04       Impact factor: 3.790

9.  Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze.

Authors:  R J Rodgers; E M Nikulina; J C Cole
Journal:  Pharmacol Biochem Behav       Date:  1994-12       Impact factor: 3.533

10.  Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine.

Authors:  E M Pich; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530
View more
  2 in total

Review 1.  The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.

Authors:  Baptiste Pignon; Chloé Tezenas du Montcel; Louise Carton; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2017-11-07       Impact factor: 5.285

Review 2.  Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review.

Authors:  Vasilios G Masdrakis; David S Baldwin
Journal:  Ther Adv Psychopharmacol       Date:  2021-03-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.